Recent regulatory changes impacting UK manufacturers, distributors and suppliers of medicines

Synopsis

This interactive session will provide an overview of the key regulatory changes, recently implemented, relating to the manufacture, importation, supply and control of medicines, within the UK, from a GxP and compliance perspective. The impact of future key changes, driven by the MHRA, EU, US FDA, ICH etc, currently awaiting implementation or under discussion, will also be assessed.

An ideal session for those wishing to recap on the implementation of the ‘Windsor Framework’ and check they haven’t missed any upcoming regulatory changes.